These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 25723494)

  • 21. The safety, efficacy, and pharmacokinetic profile of a switch in antiretroviral therapy to saquinavir, ritonavir, and atazanavir alone for 48 weeks and a switch in the saquinavir formulation.
    Winston A; Mallon PW; Satchell C; MacRae K; Williams KM; Schutz M; Law M; Cooper DA; Emery S
    Clin Infect Dis; 2007 Jun; 44(11):1475-83. PubMed ID: 17479946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of anti-viral therapy and HCV clearance on cerebral metabolism and cognition.
    Byrnes V; Miller A; Lowry D; Hill E; Weinstein C; Alsop D; Lenkinski R; Afdhal NH
    J Hepatol; 2012 Mar; 56(3):549-56. PubMed ID: 22027578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low rates of neurocognitive impairment are observed in neuro-asymptomatic HIV-infected subjects on effective antiretroviral therapy.
    Garvey L; Surendrakumar V; Winston A
    HIV Clin Trials; 2011; 12(6):333-8. PubMed ID: 22189152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of 1H-MR spectroscopy and cerebrospinal fluid biomarkers in Alzheimer's disease: diverging behavior at three different brain regions.
    Bittner DM; Heinze HJ; Kaufmann J
    J Alzheimers Dis; 2013; 36(1):155-63. PubMed ID: 23579327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Posterior paralimbic and frontal metabolite impairments in asymptomatic hypertension with different treatment outcomes.
    García Santos JM; Fuentes LJ; Vidal JB; Carrillo A; Antequera M; Campoy G; Antúnez C; Torres del Río S; García-Sevilla J; Ortega G
    Hypertens Res; 2010 Jan; 33(1):67-75. PubMed ID: 19876064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolite profile in the basal ganglia of children with cerebral palsy: a proton magnetic resonance spectroscopy study.
    Kulak W; Sobaniec W; Smigielska-Kuzia J; Kubas B; Walecki J
    Dev Med Child Neurol; 2006 Apr; 48(4):285-9. PubMed ID: 16542516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evolution of changes in cognitive function after the initiation of antiretroviral therapy.
    Mora-Peris B; Stevens E; Ferretti F; Underwood J; Taylor S; Winston A
    AIDS Res Ther; 2016; 13():20. PubMed ID: 27081393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing multiple-group diagnostic problems with multi-dimensional receiver operating characteristic surfaces: application to proton MR Spectroscopy (MRS) in HIV-related neurological injury.
    Yiannoutsos CT; Nakas CT; Navia BA;
    Neuroimage; 2008 Mar; 40(1):248-55. PubMed ID: 18191586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus.
    Sahin I; Alkan A; Keskin L; Cikim A; Karakas HM; Firat AK; Sigirci A
    J Diabetes Complications; 2008; 22(4):254-60. PubMed ID: 18413166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
    García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
    Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of 12-week administration of 20-mg long-acting methylphenidate on Glu/Cr, NAA/Cr, Cho/Cr, and mI/Cr ratios in the prefrontal cortices of school-age children in Indonesia: a study using 1H magnetic resonance spectroscopy (MRS).
    Wiguna T; Guerrero AP; Wibisono S; Sastroasmoro S
    Clin Neuropharmacol; 2012; 35(2):81-5. PubMed ID: 22318191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations in cerebrospinal fluid chemokines are associated with maraviroc exposure and in vivo metabolites measurable by magnetic resonance spectroscopy.
    Vera JH; Garvey LJ; Allsop JM; Kaye S; McClure MO; Back D; Taylor-Robinson SD; Winston A
    HIV Clin Trials; 2012; 13(4):222-7. PubMed ID: 22849963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiretroviral therapy and its influence on the stage of brain damage in patients with HIV - 1H MRS evaluation.
    Tarasów E; Wiercińska-Drapało A; Jaroszewicz J; Orzechowska-Bobkiewicz A; Dzienis W; Prokopowicz D; Walecki J
    Med Sci Monit; 2004 Jun; 10 Suppl 3():101-6. PubMed ID: 16538209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantification of diagnostic biomarkers to detect multiple sclerosis lesions employing (1)H-MRSI at 3T.
    Vafaeyan H; Ebrahimzadeh SA; Rahimian N; Alavijeh SK; Madadi A; Faeghi F; Harirchian MH; Rad HS
    Australas Phys Eng Sci Med; 2015 Dec; 38(4):611-8. PubMed ID: 26526449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. White matter proton MR spectroscopy in children with isolated developmental delay: does it mean delayed myelination?
    Fayed N; Morales H; Modrego PJ; Muñoz-Mingarro J
    Acad Radiol; 2006 Feb; 13(2):229-35. PubMed ID: 16428059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantification of metabolic differences in the frontal brain of depressive patients and controls obtained by 1H-MRS at 3 Tesla.
    Gruber S; Frey R; Mlynárik V; Stadlbauer A; Heiden A; Kasper S; Kemp GJ; Moser E
    Invest Radiol; 2003 Jul; 38(7):403-8. PubMed ID: 12821853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal metabolic and cognitive changes in mild cognitive impairment patients.
    Olson BL; Holshouser BA; Britt W; Mueller C; Baqai W; Patra S; Petersen F; Kirsch WM
    Alzheimer Dis Assoc Disord; 2008; 22(3):269-77. PubMed ID: 18580584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell-Associated HIV-1 DNA and RNA Decay Dynamics During Early Combination Antiretroviral Therapy in HIV-1-Infected Infants.
    Uprety P; Chadwick EG; Rainwater-Lovett K; Ziemniak C; Luzuriaga K; Capparelli EV; Yenokyan G; Persaud D
    Clin Infect Dis; 2015 Dec; 61(12):1862-70. PubMed ID: 26270687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multi-center 1H MRS study of the AIDS dementia complex: validation and preliminary analysis.
    Lee PL; Yiannoutsos CT; Ernst T; Chang L; Marra CM; Jarvik JG; Richards TL; Kwok EW; Kolson DL; Simpson D; Tang CY; Schifitto G; Ketonen LM; Meyerhoff DJ; Lenkinski RE; Gonzalez RG; Navia BA;
    J Magn Reson Imaging; 2003 Jun; 17(6):625-33. PubMed ID: 12766890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.